Clinical Trial Update: Retrospective Analysis of the Expression of the Neurotensin Receptor by Metastatic Lung Adenocarcinomas

View source ↗

Summary

The clinical trial investigating neurotensin receptor expression in metastatic lung adenocarcinomas has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Snippet

Sponsor: Fondation Hôpital Saint-Joseph | Conditions: Metastatic Lung Adenocarcinomas | Status: WITHDRAWN